D-1429-2012 Class I Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- August 8, 2012
- Initiation Date
- December 2, 2011
- Termination Date
- June 3, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 19,660 vials
Product Description
Argatroban Injection 50 mg per 50ml (1 mg per ml) For Intravenous Infusion Only, a) Single Use Vial (NDC 42367-203-07), b) 10 Single Use Vials(NDC 42367-203-84), Rx Only, Manufactured by: Cipla LTD, India, Manufactured for: Eagle Pharmaceuticals, Inc. Woodcliff Lake, NJ 07677 USA, Marketed by: The Medicines Company, Parsippany, NJ 07054 USA
Reason for Recall
A complaint was received from a hospital pharmacy on 11/10/11 for crystalline particulates in a single vial from Lot V10194. Additional small visible particles consisting of fibers were identified.
Distribution Pattern
New Jersey
Code Information
Lot #V10189, Lot #V10191, Lot #V10194, Exp 01/13; Lot #V10223; Exp 02/13